|
1
|
Mathers CD, Boerma T and Ma Fat DM: Global
and regional causes of death. Br Med Bull. 92:7–32. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sahly H and Podschun R: Clinical,
bacteriological, and serological aspects of Klebsiella infections
and their spondylarthropathic sequelae. Clin Diagn Lab Immunol.
4:393–399. 1997.PubMed/NCBI
|
|
3
|
Lin CY, Wheelock AM, Morin D, Baldwin RM,
Lee MG, Taff A, Plopper C, Buckpitt A and Rohde A: Toxicity and
metabolism of methylnaphthalenes: Comparison with naphthalene and
1-nitronaphthalene. Toxicology. 260:16–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jong GM, Hsiue TR, Chen CR, Chang HY and
Chen CW: Rapidly fatal outcome of bacteremic Klebsiella pneumoniae
pneumonia in alcoholics. Chest. 107:214–217. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paterson DL, Mulazimoglu L, Casellas JM,
Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM,
Klugman KP, McCormack JG and Yu VL: Epidemiology of ciprofloxacin
resistance and its relationship to extended-spectrum beta-lactamase
production in Klebsiella pneumoniae isolates causing bacteremia.
Clin Infect Dis. 30:473–478. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bratu S, Landman D, Haag R, Recco R, Eramo
A, Alam M and Quale J: Rapid spread of carbapenem-resistant
Klebsiella pneumoniae in New York City: A new threat to our
antibiotic armamentarium. Arch Intern Med. 165:1430–1435. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Antoniadou A, Kontopidou F, Poulakou G,
Koratzanis E, Galani I, Papadomichelakis E, Kopterides P, Souli M,
Armaganidis A and Giamarellou H: Colistin-resistant isolates of
Klebsiella pneumoniae emerging in intensive care unit patients:
First report of a multiclonal cluster. J Antimicrob Chemother.
59:786–790. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: A pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Renard P, Zachary MD, Bougelet C, Mirault
ME, Haegeman G, Remacle J and Raes M: Effects of antioxidant enzyme
modulations on interleukin-1-induced nuclear factor kappa B
activation. Biochem Pharmacol. 53:149–160. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lentsch AB, Czermak BJ, Bless NM and Ward
PA: NF-kappaB activation during IgG immune complex-induced lung
injury: Requirements for TNF-alpha and IL-1beta but not complement.
Am J Pathol. 152:1327–1336. 1998.PubMed/NCBI
|
|
11
|
Beg AA, Finco TS, Nantermet PV and AS Jr
Baldwin: Tumor necrosis factor and interleukin-1 lead to
phosphorylation and loss of I kappa B alpha: A mechanism for
NF-kappa B activation. Mol Cell Biol. 13:3301–3310. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brockman JA, Scherer DC, McKinsey TA, Hall
SM, Qi X, Lee WY and Ballard DW: Coupling of a signal response
domain in I kappa B alpha to multiple pathways for NF-kappa B
activation. Mol Cell Biol. 15:2809–2818. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gloire G, Legrand-Poels S and Piette J:
NF-kappaB activation by reactive oxygen species: Fifteen years
later. Biochem Pharmacol. 72:1493–1505. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Evans SE, Hahn PY, McCann F, Kottom TJ,
Pavlovic ZV and Limper AH: Pneumocystis cell wall beta-glucans
stimulate alveolar epithelial cell chemokine generation through
nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol
Biol. 32:490–497. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abraham E: The dichotomy of inhibiting
nuclear factor kappa-B in pneumonia. Crit Care. 17:1522013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Everhart MB, Han W, Sherrill TP, Arutiunov
M, Polosukhin VV, Burke JR, Sadikot RT, Christman JW, Yull FE and
Blackwell TS: Duration and intensity of NF-kappaB activity
determine the severity of endotoxin-induced acute lung injury. J
Immunol. 176:4995–5005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bakker-Woudenberg IA, ten Kate MT, Guo L,
Working P and Mouton JW: Improved efficacy of ciprofloxacin
administered in polyethylene glycol-coated liposomes for treatment
of Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents
Chemother. 45:1487–1492. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Laichalk LL, Kunkel SL, Strieter RM,
Danforth JM, Bailie MB and Standiford TJ: Tumor necrosis factor
mediates lung antibacterial host defense in murine Klebsiella
pneumonia. Infect Immun. 64:5211–5218. 1996.PubMed/NCBI
|
|
19
|
Ulich TR, Watson LR, Yin SM, Guo KZ, Wang
P, Thang H and del Castillo J: The intratracheal administration of
endotoxin and cytokines. I. Characterization of LPS-induced IL-1
and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced
inflammatory infiltrate. Am J Pathol. 138:1485–1496.
1991.PubMed/NCBI
|
|
20
|
Jones MR, Simms BT, Lupa MM, Kogan MS and
Mizgerd JP: Lung NF-kappaB activation and neutrophil recruitment
require IL-1 and TNF receptor signaling during pneumococcal
pneumonia. J Immunol. 175:7530–7535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boehm U, Klamp T, Groot M and Howard J:
Cellular responses to interferon-gamma. Annu Rev Immunol.
15:749–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maus UA, Waelsch K, Kuziel WA, Delbeck T,
Mack M, Blackwell TS, Christman JW, Schlöndorff D, Seeger W and
Lohmeyer J: Monocytes are potent facilitators of alveolar
neutrophil emigration during lung inflammation: Role of the
CCL2-CCR2 axis. J Immunol. 170:3273–3278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leung K and Nabel GJ: HTLV-1
transactivator induces interleukin-2 receptor expression through an
NF-kappa B-like factor. Nature. 333:776–778. 1988. View Article : Google Scholar : PubMed/NCBI
|
